Healthcare Value Capital, LLC - Q3 2019 holdings

$55.4 Million is the total value of Healthcare Value Capital, LLC's 22 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 0.0% .

 Value Shares↓ Weighting
GILD  GILEAD SCIENCES INC$4,437,000
-6.2%
70,0000.0%8.01%
-9.7%
TYME  TYME TECHNOLOGIES INC$2,588,000
-2.5%
2,175,0000.0%4.67%
-6.1%
VKTX  VIKING THERAPEUTICS INC$1,720,000
-17.1%
250,0000.0%3.11%
-20.2%
ADMS  ADAMAS PHARMACEUTICALS INC$1,023,000
-17.5%
200,0000.0%1.85%
-20.6%
ATRS  ANTARES PHARMA INCcall$669,000
+1.7%
200,0000.0%1.21%
-2.1%
TYME  TYME TECHNOLOGIES INCcall$119,000
-2.5%
100,0000.0%0.22%
-6.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GILEAD SCIENCES INC20Q3 202131.3%
GLAXOSMITHKLINE PLC20Q3 202116.1%
PFIZER INC19Q3 202117.9%
TYME TECHNOLOGIES INC17Q3 202140.3%
ASTRAZENECA PLC14Q3 202112.9%
QUEST DIAGNOSTICS INC14Q3 20169.5%
CRYOLIFE INC13Q1 20176.6%
ANTARES PHARMA INC13Q3 20216.7%
AMARIN CORP PLC13Q3 20214.9%
CYTOKINETICS INC13Q3 20161.7%

View Healthcare Value Capital, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Healthcare Value Capital, LLC Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NOVELION THERAPEUTICS INC.September 20, 20191,400,0007.4%

View Healthcare Value Capital, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2021-11-15
13F-HR2021-08-16
13F-HR2021-05-17
13F-HR2021-02-16
13F-HR2020-11-16
13F-HR2020-08-14
13F-HR2020-05-15
13F-HR2020-02-14
13F-HR2019-11-14
SC 13D/A2019-09-20

View Healthcare Value Capital, LLC's complete filings history.

Compare quarters

Export Healthcare Value Capital, LLC's holdings